Andrew D.C. LaFrence, CPA has been appointed senior vice president and chief financial officer, effective May 29, of Biothera Pharmaceuticals, a clinical stage immuno-oncology company. Mr. LaFrence has 34 years of accounting and finance experience, including executive management positions at public and private life sciences companies. He succeeds interim chief financial officer Steve Karel, who will continue to serve on Biothera’s board of directors.  Previously, Mr. LaFrence served as v...